In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 11, 1999, Pages 827-829

  Giacometti, A ^a   Cirioni, O ^a   Barchiesi, F ^a   Fortuna, M ^a   Scalise, G ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; INDOLIDAN; MACROLIDE; MAGAININ 2; POLYPEPTIDE ANTIBIOTIC AGENT; RIFABUTIN; RIFAMPICIN;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CRYPTOSPORIDIUM PARVUM; DRUG SENSITIVITY; HUMAN; PRIORITY JOURNAL; TIME;

EID: 0032761583     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050410     Document Type: Article

References (17)

1. Woods KM, Nesterenko MV, Upton SJ: Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro. Annals of Tropical Medicine and Parasitology (1996) 90:603-615
2. DeLucca AJ, Blond JM, Jacks TJ, Grimm C, Cleveland TE, Walsh TJ: Fungicidal activity of cecropin A. Antimicrobial Agents and Chemotherapy (1997) 41:481-483
3. Aley SB, Zimmerman M, Hetsko M, Selsted ME, Gillin FD: Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infection and Immunity (1994) 62:5397-5403
4. Falla TJ, Hancock REW: Improved activity of a synthetic indolicidin analog. Antimicrobial Agents and Chemotherapy (1997) 41:771-775
5. Zasloff M: Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proceedings of the National Academy of Sciences of the USA (1987) 84:5449-5453
6. Boman HG, Hultmark D: Cell-free immunity in insects. Annual Review of Microbiology (1987) 41:103-126
7. Cannon M: A family of wound healers. Nature (1987) 328:478
8. Clark DP, Durell S, Maloy WL, Zasloff M: Ranalexin: a novel antimicrobial peptide from bullfrog (Rana catasbeiana) skin, structurally related to the bacterial antibiotic polymyxin. Journal of Biological Chemistry (1984) 269:10849-10855
9. Vaara M, Porro M: Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. Antimicrobial Agents and Chemotherapy (1996) 40:1801-1805
10. Holmberg SD, Moorman AC, Von Bargen JC, Palella FJ, Loveless MO, Ward DJ, Navin TR: Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV diseases. JAMA (1998) 279:384-386
11. Giacometti A, Cirioni O, Scalise G: In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum. Journal of Antimicrobial Chemotherapy (1996) 38:399-408
12. Upton SJ, Tilley M, Nesterenko MV, Brillhart DB: A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa). FEMS Microbiology Letters (1994) 118:45-50
13. Arrowood MJ, Mead JR, Xie L, You X: In vitro anticryptosporidial activity of dinitroaniline herbicides. FEMS Microbiology Letters (1996) 136:245-249
14. Smith NH, Cron S, Valdez LM, Chappell CL, White AC Jr: Combination drug therapy for cryptosporidiosis in AIDS. Journal of Infectious Diseases (1998) 178:900-903
15. Theodos CM, Griffiths JK, D'Onfro J, Fairfield A, Tzipori S: Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models. Antimicrobial Agents and Chemotherapy (1998) 42:1959-1965
16. Vaara M: Agents that increase the permeability of the outer membrane. Microbiology Review (1992) 56:395-411
17. Bevins CL, Zasloff M: Peptides from frog skin. Annual Review of Biochemistry (1990) 59:395-414